1. Expression level of EGFR and MET receptors regulates invasiveness of melanoma cells
   Katarzyna Pietraszek‐Gremplewicz et al, 2019, Journal of Cellular and Molecular Medicine CrossRef
2. Suppression of GOLM1 by EGCG through HGF/HGFR/AKT/GSK-3β/β-catenin/c-Myc signaling pathway inhibits cell migration of MDA-MB-231
   Ling Xie et al, 2021, Food and Chemical Toxicology CrossRef
3. Mitochondria in oral cancer stem cells: Unraveling the potential drug targets for new and old drugs
   Ivonne Olmedo et al, 2023, Life Sciences CrossRef
4. Small Molecules in the Treatment of Squamous Cell Carcinomas: Focus on Indirubins
   Mirijam Schäfer et al, 2021, Cancers CrossRef
5. Molecularly-targeted therapy for the oral cancer stem cells
   Yuichi Ohnishi et al, 2018, Japanese Dental Science Review CrossRef
6. Curcumin inhibits epithelial‑mesenchymal transition in oral cancer cells via c‑Met blockade
   Yuichi Ohnishi et al, 2020, Oncology Letters CrossRef
7. Ligand-Independent EGFR Activation by Anchorage-Stimulated Src Promotes Cancer Cell Proliferation and Cetuximab Resistance via ErbB3 Phosphorylation
   Masami Nozaki et al, 2019, Cancers CrossRef
8. RAP1-RAC1 Signaling Has an Important Role in Adhesion and Migration in HNSCC
   M. Liu et al, 2020, Journal of Dental Research CrossRef
9. Use of MET kinase inhibitors to overcome cetuximab resistance in colorectal cancer
   Zetong Ma et al, 2023, Novel Sensitizing Agents for Therapeutic Anti-EGFR Antibodies CrossRef
10. Brain endothelial cells promote breast cancer cell extravasation to the brain via EGFR-DOCK4-RAC1 signalling
    Chiara Galloni et al, 2024, Communications Biology CrossRef
11. Combination of Selected MET and EGFR Inhibitors Decreases Melanoma Cells’ Invasive Abilities
    Aleksandra Simiczyjew et al, 2019, Frontiers in Pharmacology CrossRef
12. Hepatocyte Growth Factor Overexpression Slows the Progression of 4NQO-Induced Oral Tumorigenesis
    Xiaoxi He et al, 2021, Frontiers in Oncology CrossRef